To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
Jon Symonds, chief financial officer of AstraZeneca, is leaving the pharmaceutical group to join Goldman Sachs, as the bank looks to capitalise on his high-level influence at UK companies.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
Copyright PEI Media
Not for publication, email or dissemination